IHS FormWeb
Approved Formulary
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Search results for:
cyclophosphamide PO
cyclophosphamide PO
Brand names:
Cytoxan
Form
Strength
TABLET, ORAL
50 mg
Display
Antineoplastic Agents
,
Immunosuppressive Agents
Class:
100000
,
924400
High Alert Drug
:
Policy
Medication comments:
Administration of Cancer Chemotherapy
High Alert
Haz.Waste
Haz.Handle
High Alert Drug: Chemotherapeutic Agents - Oral
• Designated stored location in pharmacy.
• Drugs are transported in plastic bags labeled with sticker indicating CHEMOTHERAPY DRUG.
Per policy, these hazardous drugs have special waste requirements.
View all
Generic (Brand)
Waste Requirements
cyclophosphamide (Cytoxan)
If > 3% by weight of drug remains ⇒
BLACK BUCKET
Trace amounts/uncontaminated PPE ⇒
YELLOW BUCKET
USP <800> Hazardous Drug Assessment of Risk (AOR)
View all
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route
[Packaging: Manufacturer ⇒ Dispense]
Activities
cyclophosphamide (Cytoxan)
PO
[BULK ⇒ Blister UD]
50 mg capsule
Stock @ IDBH? N
NIOSH Table 1
A
↑
Pharmacy:
Receiving / Storage / Preparation
Exposure Risk: low
• Handling/preparation PPE Requirements:
Double CX glove and gown
• Receiving from Distributor:
Designated area/ CX gloves
• Pharmacy Storage Area:
Hazardous
• Packaging/Reconstitution Location:
Repackage area
• Compounding (Non-Sterile/Sterile) Location:
n/a
• Omnicell Load:
No
Transport
• Transport (dose is placed inside a plastic sealable bag):
Standard
Nursing:
Storage / Administration
Exposure Risk: low
• Handling/administration PPE Requirements:
Single pair of CX approved gloves. Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area:
Patient Med Drawer
• Signage on Patient Door Required:
Yes
• Manipulation of Dosage Form:
n/a
• Special Manipulation for Administration:
Swallow whole; do not crush or chew; do not open capsules.
Disposal / Spills
• Disposal of Drug Waste:
Full -
black bin
, Trace -
yellow bin
• Disposol of Used PPE:
yellow bin
• Spill management:
n/a
NIOSH Supplemental Information:
IARC Group 1 carcinogen; NTP
Last updated:
May. 4, 2026
Hazard.Drug Handling(USP 800)
USP<800> Hazardous Drug / Assessment of Risk
Hazardous Waste
BLACK BUCKET/YELLOW BUCKET
Chemotherapy
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
UpToDate Lexidrug
• Drugs are transported in plastic bags labeled with sticker indicating CHEMOTHERAPY DRUG.
Trace amounts/uncontaminated PPE ⇒ YELLOW BUCKET
The following outlines must be followed.
[Packaging: Manufacturer ⇒ Dispense]
[BULK ⇒ Blister UD]
NIOSH Table 1A↑
Receiving / Storage / Preparation
Storage / Administration